Ads
related to: tecfidera generic- Before & After
See Results In Photos Of
Real Patients.
- About Psoriasis
Information On Plaque Psoriasis
& Options Available For Treatment.
- Therapy Information
Alternate Therapy For Plaque
Psoriasis.
- Patient Resources
Get Tools, Personalized Info,
Talk to a Nurse and More.
- About Plaque Psoriasis
Information On Plaque Psoriasis.
Learn About A Therapy Option.
- Co-Pay Program
Learn More and See If You Are
Eligible for a Co-Pay Card.
- Before & After
Search results
Biogen holds onto Tecfidera market in Europe for a little longer
BioPharma Dive via Yahoo Finance· 5 months agoA decision by European regulators to revoke approvals for five generic versions of Biogen's multiple...
Europe revokes marketing authorization for generic versions of Biogen's MS drug
Reuters via AOL· 5 months agoWhile the patent for Biogen's drug has expired in the United States, it had scored a win in Europe...
US Supreme Court Turns Away Biogen's Last Effort To Reinstate Tecfidera Patent
Benzinga via Yahoo Finance· 2 years agoThe U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen...
Biogen (BIIB) Beats on Q2 Earnings & Sales, Ups 2022 Guidance
Zacks via Yahoo Finance· 2 years agoBiogen BIIB reported second-quarter 2022 earnings per share (EPS) of $5.25, which significantly beat...
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have lost about...
Why Is Biogen Inc. (BIIB) Up 8.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
U.S. Supreme Court turns away Biogen bid to reinstate MS drug patent
Reuters via Yahoo News· 2 years agoWASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear Biogen Inc's bid to win...
Biogen (BIIB) Q4 Earnings & Sales Miss Estimates, Stock Falls
Zacks via Yahoo Finance· 4 months agoBiogen BIIB reported fourth-quarter 2023 adjusted earnings per share (EPS) of $2.95, which missed...
Biogen (BIIB) to Report Q3 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 years agoBiogen BIIB will report third-quarter 2022 results on Oct 25, before market open. In the last...
Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business Daily· 4 months agoBiogen's turnaround is still a "work in progress," an analyst said Tuesday as Biogen stock slumped...
Ads
related to: tecfidera generic
